Simplex Trading’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$415K Buy
30,100
+29,700
+7,425% +$448K ﹤0.01% 3494
2025
Q4
$7.21K Sell
400
-6,500
-94% -$117K ﹤0.01% 7206
2025
Q3
$127K Sell
6,900
-9,000
-57% -$141K ﹤0.01% 5472
2025
Q2
$254K Sell
15,900
-39,200
-71% -$699K ﹤0.01% 4248
2025
Q1
$1.07M Buy
55,100
+21,000
+62% +$442K ﹤0.01% 2649
2024
Q4
$751K Buy
34,100
+32,800
+2,523% +$631K ﹤0.01% 3139
2024
Q3
$21K Buy
1,300
+700
+117% +$10.4K ﹤0.01% 6628
2024
Q2
$7K Sell
600
-1,500
-71% -$16.8K ﹤0.01% 7650
2024
Q1
$23K Buy
2,100
+1,600
+320% +$16.3K ﹤0.01% 6976
2023
Q4
$4K Buy
+500
New +$3.89K ﹤0.01% 7947
2023
Q3
Sell
-8,000
Closed -$57K 8766
2023
Q2
$57K Sell
8,000
-10,300
-56% -$60.1K ﹤0.01% 5708
2023
Q1
$111K Sell
18,300
-8,600
-32% -$46.6K ﹤0.01% 5034
2022
Q4
$117K Sell
26,900
-200
-0.7% -$893 ﹤0.01% 4879
2022
Q3
$106K Buy
27,100
+26,100
+2,610% +$131K ﹤0.01% 5436
2022
Q2
$5K Sell
1,000
-1,100
-52% -$5.72K ﹤0.01% 8802
2022
Q1
$13K Sell
2,100
-14,900
-88% -$98.8K ﹤0.01% 8649
2021
Q4
$136K Buy
+17,000
New +$160K ﹤0.01% 5750

Other funds holding CLBT

Simplex Trading's CLBT Position: Q1 2026 in Review

Simplex Trading reduced its Cellebrite (CLBT) stake by 59% in Q1 2026, selling an estimated $374K and leaving 17,035 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #4112.

Simplex Trading first reported a position in CLBT in Q4 2021 and has held it in 17 quarters since. The position peaked at $927K in Q3 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Simplex Trading held 17,035 shares of Cellebrite worth $235K as of Q1 2026.
  • Simplex Trading sold 24,786 Cellebrite shares in Q1 2026, an estimated $374K.
  • Cellebrite made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4112 holding.
  • Simplex Trading first reported a position in Cellebrite in Q4 2021 and has held it in 17 quarters since.
  • Simplex Trading's Cellebrite position peaked at $927K in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.